Latest filing published 12 Aug 2026 for Hepion Pharmaceuticals, Inc., €87k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +12.9%Entry US$0.07 · Close at T+30 US$0.08
- -7.1%Entry US$0.07 · Close at T+90 US$0.06
- +73.4%Entry US$1.54 · Close at T+365 US$2.66
- +30.5%Entry US$2.23 · Close at T+365 US$2.91
- +56.4%Entry US$2.02 · Close at T+365 US$3.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sireesh Appajosyula: trading record in brief
Sireesh Appajosyula is a declared insider at 2 companies; the most frequent names are Canton Strategic Holdings, Inc. and Hepion Pharmaceuticals, Inc. In total, 9 filings cover trades dated from 14 July 2022 to 3 August 2026.
Purchases make up the whole of the open-market record (7 purchases, €235k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €9,510. On 4 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +10.8%. These figures describe past trades and do not predict future prices.
Most recently, on 12 August 2026, the filings show an open-market purchase worth €87k in Hepion Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sireesh Appajosyula
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ US$0.051.74% mcap67.1% of flowCommon StockSEC:0001493152-26-037490:0Canonical exit: 1 Nov 2026 (T+90)
- 1,250,000 shares@ US$0.040.74% mcap32.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-26-019028:0Canonical exit: 20 Jul 2026 (T+90)
- 690 shares@ US$1.420.9% of flowCommon StockSEC:0001641172-25-016168:1Canonical exit: 18 Sept 2025 (T+90)
- 60,806 shares@ US$1.4881.0% of flowCommon StockSEC:0001641172-25-016168:0Canonical exit: 18 Sept 2025 (T+90)
- 5,000 shares@ US$2.01929.9% of flowCommon StockSEC:0001493152-24-045180:0Canonical exit: 11 Feb 2025 (T+90)
- 5,000 shares@ US$1.939.1% of flowCommon StockSEC:0001493152-24-040439:0Canonical exit: 6 Jan 2025 (T+90)
- 7,576 shares0Common StockSEC:0001493152-22-019586:1
- 75,757 shares0Common StockSEC:0001493152-22-019586:0
8 of 8 declarations